Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
Moonis
Majaz
M
Department of Neurology, University of Massachusetts Medical School, Worcester 01655, USA. moonism@ummhc.org
Fisher
Marc
M
D001241:Aspirin / Q000008:administration & dosage; D000068342:Aspirin, Dipyridamole Drug Combination; D000077144:Clopidogrel; D004176:Dipyridamole / Q000008:administration & dosage; D004338:Drug Combinations; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000068342:Aspirin, Dipyridamole Drug Combination; D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin